These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27272255)

  • 1. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.
    Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ
    Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].
    Liu SQ; Xue YM; Yang GC; He FY; Zhao XS
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):904-7. PubMed ID: 15321757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
    Xu F; Liu H; Sun Y
    Ren Fail; 2016; 38(1):157-62. PubMed ID: 26616527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study.
    Xu K; Liu X; Yang F; Cui D; Shi Y; Shen C; Tang W; Yang T
    PLoS One; 2013; 8(11):e79150. PubMed ID: 24223897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
    Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
    Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis.
    Zhang T; Pang C; Li N; Zhou E; Zhao K
    BMC Med; 2013 Jan; 11():1. PubMed ID: 23281898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.
    Nie W; Li B; Xiu QY
    PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
    Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
    Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
    Li YY
    PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.
    Wong TY; Poon P; Szeto CC; Chan JC; Li PK
    Kidney Int; 2000 Feb; 57(2):632-8. PubMed ID: 10652041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH; Song GG
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.
    Zhang X; Gao B; Xu B
    Medicine (Baltimore); 2020 Dec; 99(50):e23660. PubMed ID: 33327353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
    Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
    Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis.
    Wang S; Cao Q; Wang X; Li B; Tang M; Yuan W; Fang J; Qian J; Qin C; Zhang W
    PLoS One; 2013; 8(2):e56797. PubMed ID: 23437240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene and sudden sensorineural hearing loss in Caucasian population: a meta-analysis.
    Wei Z; Chang K; Fan C
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2203-2208. PubMed ID: 32901365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis.
    Liang Z; Jiang W; Ouyang M; Yang K
    Int J Clin Exp Med; 2015; 8(2):2097-107. PubMed ID: 25932140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the plasminogen activator inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G promoter polymorphism with risk of keloid in a Chinese Han population.
    Wang Y; Long J; Wang X; Sun Y
    Med Sci Monit; 2014 Oct; 20():2069-73. PubMed ID: 25350781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.
    Li L; Nie W; Zhou H; Yuan W; Li W; Huang W
    PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
    Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
    Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Chinese population.
    Cao Y; Chen W; Qian Y; Zeng Y; Liu W
    Int J Neurosci; 2014 Dec; 124(12):874-81. PubMed ID: 24472072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.